1. Home
  2. XBIO vs BQ Comparison

XBIO vs BQ Comparison

Compare XBIO & BQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xenetic Biosciences Inc.

XBIO

Xenetic Biosciences Inc.

HOLD

Current Price

$4.33

Market Cap

6.9M

Sector

Health Care

ML Signal

HOLD

Logo Boqii Holding Limited representing

BQ

Boqii Holding Limited representing

HOLD

Current Price

$0.81

Market Cap

7.7M

ML Signal

HOLD

Company Overview

Basic Information
Metric
XBIO
BQ
Founded
N/A
2008
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Specialty Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
6.9M
7.7M
IPO Year
2011
2020

Fundamental Metrics

Financial Performance
Metric
XBIO
BQ
Price
$4.33
$0.81
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
33.7K
76.1K
Earning Date
05-13-2026
01-05-2026
Dividend Yield
N/A
N/A
EPS Growth
38.52
N/A
EPS
N/A
N/A
Revenue
$2,976,411.00
N/A
Revenue This Year
$2.81
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
19.04
N/A
52 Week Low
$1.90
$0.65
52 Week High
$13.93
$72.74

Technical Indicators

Market Signals
Indicator
XBIO
BQ
Relative Strength Index (RSI) 56.96 42.12
Support Level $2.61 $0.70
Resistance Level $4.90 $0.89
Average True Range (ATR) 0.29 0.04
MACD -0.04 -0.01
Stochastic Oscillator 31.72 5.99

Price Performance

Historical Comparison
XBIO
BQ

About XBIO Xenetic Biosciences Inc.

Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing immuno-oncology technologies addressing difficult-to-treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors. Its product pipeline consists of two key programs, XBIO-015 and XBIO-020, which are being developed to address pancreatic carcinoma and solid tumours.

About BQ Boqii Holding Limited representing

Boqii Holding Ltd is a pet-focused platform in China. It offer a truly one-stop destination that pet parents in China may go to get everything it need for their pets and share their passion for pet parenting. It operate a pet-focused online retail business in China's pet market in terms of GMV. The company operates in single segment. This segment is engaged in pet products sales and online marketing and information services and other. All the company's revenues is derived from The PRC.

Share on Social Networks: